In this video, Dr. David Goodman, an NEI faculty member and Johns Hopkins expert, explores the latest advancements in psychopharmacology presented at the 2024 NEI Annual Conference. Key highlights include the emerging role of GLP-1 receptor agonists in managing diabetes and their potential to address brain inflammation. Dr. Goodman also discusses innovative treatments for ADHD and Alzheimer’s, as well as groundbreaking research into intracellular processes like mTOR pathway modulation. These insights equip physicians with actionable strategies to enhance the precision and efficacy of neurological and psychiatric care.
Use of Voice-Based Conversational Artificial Intelligence for Basal Insulin Prescription Management Among Patients With Type 2 Diabetes: A Randomized Clinical Trial - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/38039007/
ClinicalTrials.gov Identifier: NCT05081011.
A voice-based AI application significantly improved insulin titration speed, adherence, glycemic control, and reduced emotional distress in type 2 diabetes patients compared to standard care, suggesting its potential in medication management.
Management of type 2 diabetes in the new era - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/37700155/
Management of type 2 diabetes requires a holistic approach and recent breakthroughs are expected to improve the quality of care.
Advances in type 2 diabetes management emphasize cardiovascular risk stratification, with GLP-1 receptor agonists, SGLT-2 inhibitors, emerging gut hormone therapies, and evolving glucose sensor technologies enhancing holistic patient care.
Metformin and Atrial Fibrillation: A Systematic Review of Their Association - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/39139337/
Atrial fibrillation (AF) is a common cardiac arrhythmia with a significant impact on patient outcomes and healthcare systems. Given the rising incidence of AF with age and its association with...
This review analyzes five studies on metformin's impact on AF risk in T2DM, revealing mixed outcomes and highlighting the need for prospective research to clarify metformin's effects on atrial remodeling and AF prevention.
The Role of Alternative Medicine in Managing Type 2 Diabetes: A Comprehensive Review - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/38978922/
Diabetes, a chronic metabolic disorder marked by elevated blood glucose levels, is increasingly prevalent globally, significantly impacting health-related quality of life. Type 2 diabetes (T2DM), characterized by insulin resistance and...
Integrating complementary and alternative medicine (CAM) with conventional treatments for type 2 diabetes can enhance glycemic control, improve patient outcomes, and lower healthcare costs, though patient education and quality control are essential.